Krüppel cripples prostate cancer: KLF6 progress and prospects

American Journal of Pathology

Volumn 162, Issue 4, 2003, Pages 1047-1052

  Narla, Goutham ^a   Friedman, Scott L ^a   Martignetti, John A ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Box 1498 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALLELE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 10P; FAMILIAL CANCER; GENE DELETION; GENE INACTIVATION; GENE LOCUS; GENE LOSS; GENE MAPPING; GENE MUTATION; HETEROZYGOSITY LOSS; IMMEDIATE EARLY GENE; KRUPPEL LIKE FACTOR 6; MARKER GENE; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; RACE; TUMOR SUPPRESSOR GENE;

EID: 0037377699     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63901-6     Document Type: Note

References (62)

1. Jemal ATA, Murray T, Thun M: Cancer statistics. Cancer J Clin 2002, 52:23-47
2. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, Vernon SW, Cronin K, Edwards BK: The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000, 88:2398-2424
3. Scardino PT, Weaver R, Hudson MA: Early detection of prostate cancer. Hum Pathol 1992, 23:211-222
4. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A, Feigal EG: Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002, 94:2766-2792
5. Ostrander EA, Stanford JL: Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet 2000, 67:1367-1375
6. Nupponen NN, Carpten JD: Prostate cancer susceptibility genes: many studies, many results, no answers. Cancer Metastasis Rev 2001, 20:155-164
7. Rebbeck TR: Inherited genotype and prostate cancer outcomes. Cancer Epidemiol Biomarkers Prev 2002, 11:945-952
8. Isaacs W, De Marzo A, Nelson WG: Focus on prostate cancer. Cancer Cell 2002, 2:113-116
9. Chen C, Hyytinen E-R, Sun X, Helin HJ, Koivisto PA, Frierson Jr HF, Vessella RL, Dong J-T: Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol 2003, 162:1349-1354
10. Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC, Glucksman MJ, Narla J, Eng FJ, Chan AM, Ferrari AC, Martignetti JA, Friedman SL: KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 2001, 294:2563-2566
11. Rich AR: On the frequency of occurrence of occult carcinoma of the prostate. J Urol 1979, 33:215-223
12. Moore RA: The morphology of small prostatic carcinoma. J Urol 1935, 33:224-234
13. Carter HB, Piantadosi S, Isaacs JT: Clinical evidence for and implications of the multistep development of prostate cancer. J Urol 1990, 143:742-746
14. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB, Nelson WG: Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994, 91:11733-11737
15. Park JH, Walls JE, Galvez JJ, Kim M, Abate-Shen C, Shen MM, Cardiff RD: Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol 2002, 161:727-735
16. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM: Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991, 63:963-966
17. Kittles RA, Young D, Weinrich S, Hudson J, Argyropoulos G, Ukoli F, Adams-Campbell L, Dunston GM: Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk. Hum Genet 2001, 109:253-261
18. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH, Kantoff PW: The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997, 94:3320-3323
19. Powell IJ, Carpten J, Dunston G, Kittles R, Bennett J, Hoke G, Pettaway C, Weinrich S, Vijayakumar S, Ahaghotu CA, Boykin W, Mason T, Royal C, Baffoe-Bonnie A, Bailey-Wilson J, Berg K, Trent J, Collins F: African-American heredity prostate cancer study: a model for genetic research. J Natl Med Assoc 2001, 93:25S-28S
20. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC: Family history and the risk of prostate cancer. Prostate 1990, 17:337-347
21. Gronberg H, Damber L, Damber JE: Studies of genetic factors in prostate cancer in a twin population. J Urol 1994, 152:1484-1487
22. Page WF, Braun MM, Partin AW, Caporaso N, Walsh P: Heredity and prostate cancer: a study of World War II veteran twins. Prostate 1997, 33:240-245
23. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 34:78-85
24. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC: Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992, 89:3367-3371
25. Gronberg H, Damber L, Damber JE: Studies of genetic factors in prostate cancer in a twin population. J Urol 1994, 152:1484-1487
26. Schaid DJ, McDonnell SK, Blute ML, Thibodeau SN: Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 1998, 62:1425-1438
27. Fearon E: Human cancer syndromes: clues to the origin and nature of cancer. Science 1997, 278:1043-1050
28. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA: A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001, 27:172-180
29. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Gronberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W, Trent J: Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002, 30:181-184
30. Xu J, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, Hu JJ, Sterling D, Lange EM, Hawkins GA, Turner A, Ewing CM, Faith DA, Johnson JR, Suzuki H, Bujnovszky P, Wiley KE, DeMarzo AM, Bova GS, Chang B, Hall MC, McCullough DL, Partin AW, Kassabian VS, Carpten JD, Bailey-Wilson JE, Trent JM, Ohar J, Bleecker ER, Walsh PC, Isaacs WB, Meyers DA: Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 2003, 32:321-325
31. Rokman A, Ikonen T, Seppala EH, Nupponen N, Autio V, Mononen N, Bailey-Wilson J, Trent J, Carpten J, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Schleutker J: Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 2002, 70:1299-1304
32. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN: Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 2002, 71: 116-123
33. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS: RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 2002, 32:581-583
34. Karan D, Lin MF, Johansson SL, Batra SK: Current status of the molecular genetics of human prostatic adenocarcinomas. Int J Cancer 2003, 103:285-293
35. Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC: p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res 1993, 53:3369-3373
36. Pesche S, Latil A, Muzeau F, Cussenot O, Fournier G, Longy M, Eng C, Lidereau R: PTEN/MMAC1/TEP1 involvement in primary prostate cancers. Oncogene 1998, 16:2879-2883
37. Wang SI, Parsons R, Ittmann M: Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clin Cancer Res 1998, 4:811-815
38. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, Bova GS: Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 1998, 58:204-209
39. Carter BS, Epstein JI, Isaacs WB: Ras gene mutations in human prostate cancer. Cancer Res 1990, 50:6830-6832
40. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH: Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 1996, 56:3091-3102
41. Kubota Y, Fujinami K, Uemura H, Dobashi Y, Miyamoto H, Iwasaki Y, Kitamura H, Shuin T: Retinoblastoma gene mutations in primary human prostate cancer. Prostate 1995, 27:314-320
42. Bieker JJ: Kruppel-like factors: three fingers in many pies. J Biol Chem 2001, 276:34355-34358
43. Black AR, Black JD, Azizkhan-Clifford J: Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001, 188:143-160
44. Ratziu V, Lalazar A, Wong L, Dang Q, Collins C, Shaulian E, Jensen S, Friedman SL: Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci USA 1998, 95:9500-9505
45. Koritschoner NP, Bocco JL, Panzetta-Dutari GM, Dumur CI, Flury A, Patrito LC: A novel human zinc finger protein that interacts with the core promoter element of a TATA box-less gene. J Biol Chem 1997, 272:9573-9580
46. Kojima S, Hayashi S, Shimokado K, Suzuki Y, Shimada J, Crippa MP, Friedman SL: Transcriptional activation of urokinase by the Kruppellike factor Zf9/COPEB activates latent TGF-β1 in vascular endothelial cells. Blood 2000, 95:1309-1316
47. Inuzuka H, Nanbu-Wakao R, Masuho Y, Muramatsu M, Tojo H, Wakao H: Differential regulation of immediate-early gene expression in preadipocyte cells through multiple signaling pathways. Biochem Biophys Res Commun 1999, 265:664-668
48. Botella LM, Sanchez-Elsner T, Sanz-Rodriguez F, Kojima S, Shimada J, Guerrero-Esteo M, Cooreman MP, Ratziu V, Langa C, Vary CP, Ramirez JR, Friedman S, Bernabeu C: Transcriptional activation of endoglin and transforming growth factor-β signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood 2002, 100:4001-4010
49. Okano J, Opitz OG, Nakagawa H, Jenkins TD, Friedman SL, Rustgi AK: The Kruppel-like transcriptional factors Zf9 and GKLF coactivate the human keratin 4 promoter and physically interact. FEBS Lett 2000, 473:95-100 50.
50. Haber D, Harlow E: Tumour-suppressor genes: evolving definitions in the genomic age. Nat Genet 1997, 16:320-322
51. Knudson Jr AG: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971, 68:820-823
52. Ittmann M: Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res 1996 56:2143-2147
53. Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M, Sato F, Meltzer SJ, Sidransky D: Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2002, 2:485-495
54. Frayling IM: Methods of molecular analysis: mutation detection in solid tumours. Mol Pathol 2002, 55:73-79
55. Gonzalez-Garcia I, Sole RV, Costa J: Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci USA 2002, 99: 13085-13089
56. Owonikoko T, Rees M, Gabbert HE, Sarbia M: Intratumoral genetic heterogeneity in Barrett adenocarcinoma. Am J Clin Pathol 2002, 117:558-566
57. Tomlinson I, Sasieni P, Bodmer W: How many mutations in a cancer? Am J Pathol 2002, 160:755-758
58. Brenner S, Johnson M, Bridgham J, Golda G, Lloyd DH, Johnson D, Luo S, McCurdy S, Foy M, Ewan M, Roth R, George D, Eletr S, Albrecht G, Vermaas E, Williams SR, Moon K, Burcham T, Pallas M, DuBridge RB, Kirchner J, Fearon K, Mao J, Corcoran K: Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays Nature Biotechnol 2000, 18:630-634
59. Mei R, Galipeau PC, Prass C, Berno A, Ghandour G, Patil N, Wolff RK, Chee MS, Reid BJ, Lockhart DJ: Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res 2000, 8:1126-1137
60. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA: Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954
61. Wikman H, Kettunen E, Seppanen JK, Karjalainen A, Hollmen J, Anttila S, Knuutila S: Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array Oncogene 2002, 21:5804-5813
62. Chen HK, Liu XQ, Lin J, Chen TY, Feng QS, Zeng YX: Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas (in Chinese) Ai Zheng 2002, 21:1047-1050